Cite
HARVARD Citation
Haag, G. et al. (2022). Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer – The PICCASSO phase I trial. European journal of cancer. pp. 112-122. [Online].